Skip to main content
See the bias in every story
Published • loading... • Updated

Salubris Biotherapeutics Announces Updated Phase 1b/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the European Society for Medical Oncology Congress 2026

Summary by WBOC 16
JK06 continued to demonstrate a highly differentiated safety profile for an MMAE ADC among 230 patients in the target

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WBOC 16 broke the news on Friday, October 23, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal